Moodley, K., et al., Submitted. A framework for tiered informed consent for health genomic research in Africa.

Mampunye, L., et al., Submitted. Pioneering BRCA1/2 point-of-care testing for integration of germline and tumor genetics in breast cancer risk management: A vision for the future of translational pharmacogenomics. Frontiers in Oncology, p.3732.

RISPAH, T., et al., Submitted. Risk Factors Associated with Aggressive Breast Cancer Forms Seen in Young Women of Western Kenya.

Torrorey-Sawe, R. & Kotze, M., 2020. Identification of Pro-inflammatory Gene Variants in Triple Negative Breast Cancer Patients. Federation of Clinical Immunology Societies, October 28-31, 2020(October 28-31, 2020), p.173.

Torrorey-Sawe, R. & Kotze, M., 2020. Identification of Pro-inflammatory Gene Variants in Triple Negative Breast Cancer Patients. Federation of Clinical Immunology Societies, October 28-31, 2020(October 28-31, 2020), p.173.

Okunola, A.O., 2020. Investigation of the role of vitamin D metabolism in South African breast cancer patients using a pathology-supported genetic testing platform. Stellenbosch: Stellenbosch University.

Sawe, R.T., et al., 2020. Pioneering informed consent for return of research results to breast cancer patients facing barriers to genomic medicine in Africa: The Kenyan BRCA1/2 testing experience. Frontiers in Genetics, 11, p.170.

Torrorey-Sawe, R., et al., 2020. Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing. Frontiers in genetics, 11, p.170.

Nembaware, V., et al., 2019. A framework for tiered informed consent for health genomic research in Africa. Nature genetics, 51, p.1566–1571.

Sawe, R.T., et al., 2017. Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya. Tropical medicine and health, 45, p.1–11.

Sawe, R.T., et al., 2016. Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration. BMC cancer, 16, p.1–15.

RISPAH, T., 2016. Characterization of breast cancer intrinsic subtypes in relation to risk factors, tumor grade and tumor infiltrating leukocytes in Western Kenya. Maseno University.

Torrorey, R., et al., 2014. Molecular profiling of aggressive breast cancer in a unique patient population from Kenya.

Ja, R.S. & others, 2009. Evaluation of Factors Predisposing to Bacterial Contamination of Drinking Water Sources: A study at Kitale Municipality, Kenya.

Rono Salinah, J., et al., 2009. Evaluation of Factors Predisposing to Bacterial Contamination of Drinking Water Sources: A study at Kitale Municipality, Kenya.